Farmaceutisch concern · Japan
Takeda
Een concern van 73 bedrijven met 1.198 geneesmiddelen in 12 landen.
Concernstructuur
73 bedrijven in 23 landen
Je pagina wordt geladen…
Je pagina wordt geladen…
Farmaceutisch concern · Japan
Een concern van 73 bedrijven met 1.198 geneesmiddelen in 12 landen.
73 bedrijven in 23 landen
Eén gratis account voor de Prognia-apps: Ward om te studeren, Osler voor klinische antwoorden met hun bronnen, en het netwerk om je collega’s te vinden.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Alle geneesmiddelen van alle bedrijven in het concern, actuele eerst.
1–25 van 1.198
| Geneesmiddel | Werkzame stof | Land | Status | Toelating |
|---|---|---|---|---|
| ACTOPLUS MET500MG; 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 850MG; 15MG BASE · Tablet | Metformin, Pioglitazone | Verenigde Staten | In de handel | 2005 |
| ACTOPLUS MET XR1gm; 15mg base | 1gm; 30mg base · Tablet, extended release | Metformin, Pioglitazone | Verenigde Staten | Niet in de handel | 2009 |
| ACTOS15mg base | 30mg base | 45mg base · Tablet | Pioglitazone | Verenigde Staten | In de handel | 1999 |
| ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spanje | In de handel | 2020 |
| ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido | Pioglitazone | Spanje | In de handel | 2020 |
| Adcetris | Brentuximab vedotin | EU (EMA) | Toegelaten | 2012 |
| ADCETRIS | Brentuximab vedotin | Brazilië | Toegelaten | 2026 |
| ADCETRISConcentrato per soluzione per infusione | Brentuximab vedotin | Italië | Toegelaten | |
| Adcetris 50 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Brentuximab vedotin | Nederland | Toegelaten | 2012 |
| ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION50 mg · Polvo para concentrado para solución para perfusión | Brentuximab vedotin | Spanje | Toegelaten | 2021 |
| ADCETRIS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION50 mg · Polvo para concentrado para solución para perfusión | Brentuximab vedotin | Spanje | In de handel | 2012 |
| Adcetris®50mg · prašak za koncentrat za rastvor za infuziju | Brentuximab vedotin | Servië | Toegelaten | 2023 |
| ADCETRIS® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL50mg/vial · Injection, powder, for solution | Brentuximab vedotin | Singapore | Toegelaten | 2014 |
| ADDERALL XR10 mg · Capsule (Extended-Release) | Amfetamine | Canada | In de handel | 2004 |
| ADDERALL XR5 mg · Capsule (Extended-Release) | Amfetamine | Canada | In de handel | 2004 |
| ADDERALL XR20 mg · Capsule (Extended-Release) | Amfetamine | Canada | In de handel | 2004 |
| ADDERALL XR15 mg · Capsule (Extended-Release) | Amfetamine | Canada | In de handel | 2004 |
| ADDERALL XR25 mg · Capsule (Extended-Release) | Amfetamine | Canada | In de handel | 2004 |
| ADDERALL XR30 mg · Capsule (Extended-Release) | Amfetamine | Canada | In de handel | 2004 |
| ADDERALL XR 102.5mg; 2.5mg; 2.5mg; 2.5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Verenigde Staten | In de handel | 2001 |
| ADDERALL XR 153.75mg; 3.75mg; 3.75mg; 3.75mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Verenigde Staten | In de handel | 2001 |
| ADDERALL XR 205mg; 5mg; 5mg; 5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Verenigde Staten | In de handel | 2001 |
| ADDERALL XR 256.25mg; 6.25mg; 6.25mg; 6.25mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Verenigde Staten | In de handel | 2001 |
| ADDERALL XR 307.5mg; 7.5mg; 7.5mg; 7.5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Verenigde Staten | In de handel | 2001 |
| ADDERALL XR 51.25mg; 1.25mg; 1.25mg; 1.25mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Verenigde Staten | In de handel | 2001 |
Waar het geneesmiddelen registreert of maakt, en hoeveel daarvan actueel zijn.
| Land | Geneesmiddelen | Actueel | Vroeger | Bedrijven |
|---|---|---|---|---|
| Spanje | 210 | 178 | 32 | BedrijvenAlle geneesmiddelen |
| Brazilië | 195 | 56 | 139 | BedrijvenAlle geneesmiddelen |
| Canada | 159 | 119 | 40 | BedrijvenAlle geneesmiddelen |
| Verenigde Staten | 147 | 146 | 1 | BedrijvenAlle geneesmiddelen |
| Nederland | 114 | 114 | 0 | BedrijvenAlle geneesmiddelen |
| Saoedi-Arabië | 110 | 110 | 0 | BedrijvenAlle geneesmiddelen |
| Italië | 53 | 53 | 0 | BedrijvenAlle geneesmiddelen |
| Servië | 53 | 53 | 0 | BedrijvenAlle geneesmiddelen |
| Singapore | 50 | 50 | 0 | BedrijvenAlle geneesmiddelen |
| Roemenië | 49 | 0 | 49 | BedrijvenAlle geneesmiddelen |
| Europese Unie (EMA) | 48 | 36 | 12 | BedrijvenAlle geneesmiddelen |
| Kroatië | 10 | 10 | 0 | BedrijvenAlle geneesmiddelen |
Ook geregistreerd in: Frankrijk, Verenigd Koninkrijk
De ATC-groepen waartoe de meeste van zijn geneesmiddelen behoren, grootste eerst.
De werkzame stoffen in de meeste van zijn geneesmiddelen.
Hoe de registers de naam schrijven, genormaliseerd: zonder rechtsvorm, accenten en hoofdletters.
Samengesteld door Prognia uit de openbare geneesmiddelen- en bedrijfsregisters hieronder. Logo’s worden niet gebruikt.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licentie: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licentie: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licentie: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licentie: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licentie: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licentie: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Estonian Centre of Registers and Information Systems (RIK), e-Business Register open general data; exact registry code, field locator, source Last-Modified and retrieval date. CC BY 4.0 International; selected corporate field export/normalization by Prognia.
Licentie: Creative Commons Attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licentie: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licentie: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licentie: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licentie: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licentie: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licentie: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licentie: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licentie: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licentie: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licentie: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licentie: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Meld een fout of vraag verwijdering aanCorrecties van het bedrijf zelf zijn welkom.
Houd de geneesmiddelen van Takeda op Prognia juist, zie hoe zorgprofessionals ze gebruiken en beantwoord wat ze vragen. Een gesprek van 20 minuten, in het Engels.
Plan een gesprekBekende farmaceutische concerns, elk met al zijn bedrijven.
Gerangschikt naar hun aantal geneesmiddelen.